A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.
about
The Role of Crk Adaptor Proteins in T-Cell Adhesion and MigrationDomain organization differences explain Bcr-Abl's preference for CrkL over CrkIIOncogenic Signaling Adaptor ProteinsA pre-metazoan origin of the CRK gene family and co-opted signaling networkCrk and CrkL are required for cell transformation by v-fos and v-ras.Models of crk adaptor proteins in cancer.Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemiaFrom Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and BeyondHDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABLCaveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cellsNatural course and biology of CML.Drug target optimization in chronic myeloid leukemia using innovative computational platform.Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma.Structural biology: CrkL is not Crk-like.Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines.Structure-guided design of a potent peptide inhibitor targeting the interaction between CRK and ABL kinase
P2860
Q26779209-D106329C-7E64-4A87-8AAF-1FD2F98E4EDEQ27679069-886FAD0F-D330-47DE-A7CC-5A4140D6A9DBQ28082384-E5EF8060-DAB4-4840-BF28-ADD3E29D7D29Q30008856-7F91526E-077A-4A3E-8DDD-55A58ED32340Q30009251-37C98796-FD64-4CAD-8D3F-1CB0C3E337E8Q30009961-01A0D279-11A5-4DFB-A3D7-2301BD89CA6AQ34076003-5C6B8588-3274-40EA-A0DC-A1D5CF73FD16Q34972855-6B1DF721-C5DE-41C3-96BD-950C7343687BQ34988013-93C7440C-62AE-43B9-AD61-231EBED1CB46Q35025461-444DCC93-1FC5-4177-81C4-DB1B913FFF34Q36525865-47EEE47F-0947-4180-AFB9-B1FDCCD3D1A3Q37027483-BF5B462E-4EF2-4E6A-818A-43188E86E7B9Q37409768-822C04B1-722A-4799-BB4F-B39925037A61Q38392667-7461C96E-0C74-4495-B4B0-81FFC3485654Q41490128-3C16F27D-BB7C-44D6-B6A3-866F938C9160Q42632659-F348F137-2961-473E-BDE7-7B307C4C6AF7Q47831650-388D2977-BD8D-4D30-BC95-9EBA2BB1AEFEQ49217724-7A9A67C7-F1B9-4D85-810D-5BFEF7C58A99Q54301393-A92DA80B-B549-46C2-92F1-7D3F910F45C0Q57752535-69C911CA-0B3E-4752-90C4-8C1EFF550EF1
P2860
A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@en
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@nl
type
label
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@en
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@nl
prefLabel
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@en
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@nl
P2093
P2860
P1433
P1476
A specific need for CRKL in p2 ...... use hematopoietic progenitors.
@en
P2093
Akira Imamoto
Anupriya Agarwal
Collin R Elsea
Ian J Griswold
Ji-Heui Seo
Michael W N Deininger
Thomas O'Hare
P2860
P304
P356
10.1158/0008-5472.CAN-10-0607
P407
P577
2010-08-31T00:00:00Z